Retinoid homeostasis in major depressive disorder

Area of Science:

• Neuroscience
• Biochemistry
• Psychiatry

Background:

• Retinoic acid (RA) is crucial for neurobiological processes implicated in depression, including synaptic plasticity and neuroinflammation.
• Evidence suggests retinoid homeostasis is dysregulated in depression, but peripheral markers remain under-investigated.
• RA influences dopaminergic signaling and neuroendocrine regulation, processes relevant to mood disorders.

Purpose of the Study:

• To investigate the association between peripheral retinoid homeostasis and major depressive disorder (MDD).
• To compare retinoid metabolism parameters between MDD patients and healthy controls.
• To explore potential sex differences in retinoid homeostasis alterations in MDD.

Main Methods:

• Quantified serum concentrations of all-trans retinoic acid (at-RA) and its precursor retinol (ROL) in 109 MDD patients and controls.
• Assessed in vitro at-RA synthesis and degradation activity using peripheral blood mononuclear cell (PBMC) microsomes.
• Measured mRNA expression of key enzymes involved in retinoid signaling, transport, and metabolism.

Main Results:

• MDD patients exhibited significantly higher serum retinol (ROL) levels compared to healthy controls.
• Patients with MDD demonstrated significantly greater in vitro at-RA synthesis activity.
• Alterations in retinoid homeostasis associated with MDD showed differences between males and females.

Conclusions:

• This study provides the first evidence of altered peripheral retinoid homeostasis in a well-matched cohort of MDD patients.
• Elevated ROL levels and increased at-RA synthesis activity suggest a dysregulated vitamin A metabolism in depression.
• Findings support a role for the retinoid system in the pathophysiology of MDD and highlight potential sex-specific mechanisms.